Labcorp Holdings Inc. (LON:0JSY)
London · Delayed Price · Currency is GBP · Price in USD 284.47
-3.39 (-1.18%)
Feb 12, 2026, 4:27 PM GMT
Labcorp Holdings Market Cap
Labcorp Holdings has a market cap or net worth of 17.61 billion as of February 12, 2026. Its market cap has increased by 5.38% in one year.
Market Cap
17.61B
Enterprise Value
22.01B
Revenue
10.24B
Ranking
n/a
PE Ratio
27.68
Stock Price
284.47
Market Cap Chart
Since July 20, 1992, Labcorp Holdings's market cap has increased from 1.07B to 17.61B, an increase of 1,541.37%. That is a compound annual growth rate of 8.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 17.61B | 13.98% |
| Dec 31, 2025 | 15.45B | 0.86% |
| Dec 31, 2024 | 15.32B | 1.13% |
| Dec 29, 2023 | 15.15B | -12.51% |
| Dec 30, 2022 | 17.32B | -22.03% |
| Dec 31, 2021 | 22.21B | 52.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.68B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| Convatec Group | 4.37B |
| Hikma Pharmaceuticals | 3.43B |
| Genus | 2.09B |
| HUTCHMED (China) | 1.88B |